EFFECT OF SEROTONERGIC LESION ON ANXIOUS BEHAVIOR MEASURED IN THE ELEVATED PLUS-MAZE TEST IN THE RAT

被引:114
|
作者
BRILEY, M
CHOPIN, P
MORET, C
机构
[1] Centre de Recherche Pierre Fabre, Castres, F-81100, 17, Avenue Jean Moulin
关键词
5,7-DHT lesion; [!sup]3[!/sup]H]Paroxetine binding; Anxiety; Cortex; Hippocampus; Serotonin levels;
D O I
10.1007/BF02244124
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
5,7-Dihydroxytryptamine (250 μg) was administered intracerebroventricularly to rats to lesion central serotonergic neurones. Fourteen days later the rats were tested in the elevated plus-maze "anxiety" model in comparison to sham lesioned animals. Twenty-four hours later, the rats were killed and serotonin levels and [3H]paroxetine binding measured in cortical and hippocampal membranes. The lesion destroyed 81% of the serotonergic innervation in the cortex and 99% in the hippocampus as determined by endogenous serotonin levels. Lesioned rats had an increased ratio of open/total arm entries in the elevated plus-maze, reflecting a decreased level of "anxiety". These results are compatible with the implication of serotonin in the control of anxiety and suggest that an anxiolytic effect may be induced by lowering the level of serotonergic activation. © 1990 Springer-Verlag.
引用
收藏
页码:187 / 189
页数:3
相关论文
共 50 条
  • [31] Behavioral profile of wild mice in the elevated plus-maze test for anxiety
    Holmes, A
    Parmigiani, S
    Ferrari, PF
    Palanza, P
    Rodgers, RJ
    PHYSIOLOGY & BEHAVIOR, 2000, 71 (05) : 509 - 516
  • [32] Effects of under- and overcrowding on exploratory behavior in the elevated plus-maze
    Botelho, S.
    Estanislau, C.
    Morato, S.
    BEHAVIOURAL PROCESSES, 2007, 74 (03) : 357 - 362
  • [33] Factor analysis of elevated plus-maze behavior in adolescent and adult rats
    Doremus, Tamara L.
    Varlinskaya, Elena I.
    Spear, Linda P.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 83 (04) : 570 - 577
  • [34] Elevated plus-maze behavior in adult offspring of selectively bred rats
    Dichter, GS
    Brunelli, SA
    Hofer, MA
    PHYSIOLOGY & BEHAVIOR, 1996, 60 (01) : 299 - 304
  • [35] The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test
    Sumnall, HR
    O'Shea, E
    Marsden, CA
    Cole, JC
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 77 (04) : 805 - 814
  • [36] Oxycodone decreases anxiety-like behavior in the elevated plus-maze test in male and female rats
    Bruijnzeel, Adriaan W.
    Behnood-Rod, Azin
    Malphurs, Wendi
    Chellian, Ranjithkumar
    Caudle, Robert M.
    Febo, Marcelo
    Setlow, Barry
    Neubert, John K.
    BEHAVIOURAL PHARMACOLOGY, 2022, 33 (06): : 418 - 426
  • [37] Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat
    Gower, AJ
    Falter, U
    Lamberty, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 481 (01) : 67 - 74
  • [38] Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test
    Silvestre, JS
    Fernandez, AG
    Palacios, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (03) : 219 - 222
  • [39] CHRONIC HANDLING MODIFIES THE ANXIOLYTIC EFFECT OF DIAZEPAM IN THE ELEVATED PLUS-MAZE
    BRETT, RR
    PRATT, JA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 178 (01) : 135 - 138
  • [40] EFFECT OF AGE AND MAGNESIUM ADMINISTRATION ON THE PERFORMANCE OF SHR IN THE ELEVATED PLUS-MAZE
    OLIVEIRA, GM
    ROSA, WCM
    NAKAMURAPALACIOS, EM
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1995, 28 (03) : 343 - 346